Startup Dossier
Cyllene Therapeutics
Pioneering a new approach in gene therapy, called pinpoint gene therapy, focusing on targeted neurological applications.
active
Typestartup
SectorBioTech
LocationParis
About
Pioneering a new approach in gene therapy, called pinpoint gene therapy, focusing on targeted neurological applications.
Structural DNA
Legal Name
ELPIS
SIREN
851225599
Founders & Team
Funding Lineage
Series C
5 investors
€33.0M
Jul 2026
Series B
Bpifrance (Lead)
€27.0M
Feb 2025
Series A
0 investors
€5.2M
Jul 2023
Series A
0 investors
€12.0M
Mar 2021